Royal Bank Of Canada Synaptogenix, Inc. Transaction History

Royal Bank Of Canada

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.78 - $1.0 $188 - $242	-242 Reduced 67.22%	118 $0
Q4 2022 Feb 14, 2023	BUY	$1.02 - $181.75 $278 - $49,617	273 Added 313.79%	360 $0
Q3 2022 Nov 14, 2022	BUY	$4.6 - $172.25 $400 - $14,985	87 New	87 $1,000
Q1 2022 May 16, 2022	SELL	$6.31 - $10.09 $3,155 - $5,045	-500 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$5.12 - $11.13 $2,560 - $5,565	500 New	500 $5,000

30K

Ticker SNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 6,840,630
Market Cap $21.2M
Description
Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodeg...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.